Cardiac metastases are common (25%) in patients with soft-tissue sarcoma and frequently produce cardiac symptoms such as congestive heart failure.
Answers are grounded in this paper and cite their sources.
Cardiac evaluation may be warranted in symptomatic soft-tissue sarcoma; Level 5 data leave open routine screening recommendations.
Cardiac metastases were present in 30 of 120 (25%) consecutive autopsies of patients with soft-tissue sarcoma (STS). Fifty percent of the patients had metastases to the myocardium, while 33% had pericardial metastases and 17% had both. Congestive heart failure was present in ten patients and was commonly caused by diffuse myocardial or restrictive pericardial metastases. Other signs and symptoms of cardiac involvement by STS included chest pain (three patients), arrhythmias (two), conduction block (two), simulation of an atrial myxoma (one), and sudden death (one). Echocardiography was used infrequently, but was diagnostic in 80% of cases in which it was used. We conclude that metastatic STS commonly involves the heart and produces cardiac symptoms.
No takes yet. Share an insight, caveat, or question.
Hallahan et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: